[Nonalcoholic fatty liver disease and psoriasis].
Hospital Universitario 12 De Octubre, Madrid, España. rriveradiaz@hotmail.com
R
R
Rivera
F
F
Vanaclocha
D002318:Cardiovascular Diseases / Q000453:epidemiology; D015897:Comorbidity; D016207:Cytokines / Q000502:physiology; D005234:Fatty Liver / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D007249:Inflammation / Q000453:epidemiology / Q000503:physiopathology; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000209:etiology; D024821:Metabolic Syndrome / Q000453:epidemiology; D065626:Non-alcoholic Fatty Liver Disease; D009765:Obesity / Q000453:epidemiology; D011565:Psoriasis / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D014463:Ultrasonography
D016207:Cytokines; D007166:Immunosuppressive Agents